• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>GlaxoSmithKline

GlaxoSmithKline

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. GlaxoSmithKline Files US Regulatory Application for Sirukumab in Rheumatoid Arthritis

    GlaxoSmithKline Files US Regulatory Application for Sirukumab in Rheumatoid Arthritis

  2. GlaxoSmithKline Names Emma Walmsley as Chief Executive Officer Designate

    GlaxoSmithKline Names Emma Walmsley as Chief Executive Officer Designate

  3. GlaxoSmithKline Names Emma Walmsley as Next Chief Executive -- 3rd Update

    GlaxoSmithKline Names Emma Walmsley as Next Chief Executive -- 3rd Update

  4. GlaxoSmithKline Names Emma Walmsley as Next Chief Executive -- Update

    GlaxoSmithKline Names Emma Walmsley as Next Chief Executive -- Update

  5. FTSE 100 becalmed as traders wait for central banks

    FTSE 100 becalmed as traders wait for central banks

  6. Vaccine Market Worth $77.5 Billion by 2024 - Analysis By Type & Application - Research and Markets

    Vaccine Market Worth $77.5 Billion by 2024 - Analysis By Type & Application - Research and Markets

  7. Influenza Market 2015-2020: Global Industry Perspective, Comprehensive Analysis and Forecasts Featuring AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline , Novartis, Sanofi-Pasteur - Research and Markets

    Influenza Market 2015-2020: Global Industry Perspective, Comprehensive Analysis and Forecasts Featuring AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline , Novartis, Sanofi-Pasteur - Research and Markets

  8. Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: GlaxoSmithKline , Allergan, SFBC - Research and Markets

    Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: GlaxoSmithKline , Allergan, SFBC - Research and Markets

  9. News Highlights: Top Equities Stories of the Day

    News Highlights: Top Equities Stories of the Day

  10. News Highlights: Top Equities Stories of the Day

    News Highlights: Top Equities Stories of the Day

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.